SynthesisThe Cochrane database of systematic reviews2022

Certolizumab pegol for maintenance of medically induced remission in Crohn's disease.

Shinji Okabayashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.